Skip to main content
OpenTrials
Completed

NCT Number: NCT01418976

Walking and Balance Post-TBI

This is a case series study evaluating the feasibility and dosage of Intensive Mobility Training (IMT). Twelve participants with chronic, mild-to-moderate, Traumatic Brain Injury (TBI) causing significant locomotor impairment, who meet these specific criteria, will be recruited. Location and nature of neural insult will be determined by multimodal Magnetic Resonance Imaging (MRI) exam. All participants will receive 3 hours of rehabilitation per day for 20 days, focusing on gait and balance. Locomotion and balance will be comprehensively tested prior to IMT, after 10 days of IMT, and then again after the full dose of IMT. This study will determine the feasibility of this intervention in the population of TBI patients, allow an estimate of effect size and provide initial information on possible neural predictors of success. Furthermore the investigators will be able to determine whether the dosage of 10 days is sufficient or whether significant improvements are made with 20 days of the intervention.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

921 Assembly Street, 3rd Floor, Public Health Research Center, University of South Carolina

Columbia, South Carolina, 29208, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • greater than 3 months post-TBI (as defined by INTRuST criteria) and no longer receiving care as an inpatient in a rehabilitation facility.
  • the ability to follow simple three-step commands;
  • the ability to communicate presence and location of pain;
  • the ability to sit independently without back or arm support for five minutes;
  • the ability to stand with support of a straight cane, quad cane, or walker for 2 minutes;
  • the ability to walk 10 meters with maximum 1 person assisting;
  • presence of motor deficits (determined by clinical assessment of paresis);
  • age ≥ 18;
  • ability to give consent or have a acceptable surrogate capable of giving consent on subject's behalf

Exclusion criteria

  • unable to ambulate 500 feet prior to TBI;
  • history of serious chronic obstructive pulmonary disease or oxygen dependence;
  • severe weight bearing pain;
  • lower-extremity amputation;
  • non-healing ulcers on the lower-extremity;
  • renal dialysis or end stage liver disease;
  • legal blindness or severe visual impairment;
  • severe arthritis or orthopedic problems that limit passive ranges of motion of lower extremity (knee flexion contracture of -10°, knee flexion Range of Motion < 90°, hip flexion contracture > 25°, and ankle plantar flexion contracture > 15°);
  • history of deep venous thrombosis or pulmonary embolism within 6 months
  • uncontrollable diabetes with recent weight loss, diabetic coma, or frequent insulin reactions;
  • severe hypertension with systolic greater than 200 mmHg and diastolic greater than 110 mmHg at rest;
  • intracranial hemorrhage related to aneurysm rupture or an arteriovenous malformation (hemorrhagic infarctions will not be excluded);
  • history of severe uncontrolled seizure disorder;
  • other neurological conditions such as multiple sclerosis or Parkinson's Disease;
  • pain that is scored greater than 5 out of 10 on a visual analog scale;
  • any factor contraindicative to MRI examination (e.g., cardiac pacemaker/ defibrillator, pregnancy, aneurysm clips, insulin pump, metal fragments in the body).
  • any other health problems judged by their screening physician to put the client at significant risk of harm during the study

Treatment and study plan

Intensive Mobility Training (IMT)

Behavioral

Intensive Mobility Training will be used as an intensive physical therapy intervention. Participants will receive 3 hours per day for a 10 day session, be post-tested, and receive another 10 day session followed by two more testing sessions.

Primary outcomes

  1. Feasibility as measured by study completion.

    Time frame: post-treatment (after 20-day intervention)

    Feasibility will be determined by the ratio of participants that complete the intervention.

  2. Feasibility as measured by pain ratings.

    Time frame: during 20-day intervention

    Feasibility will be determined by daily change in pain scores as measured using visual analog scales.

  3. Feasibility as measured by fatigue ratings.

    Time frame: during 20-day intervention

    Feasibility will be determined by daily change in fatigue scores as measured using visual analog scales.

Secondary outcomes

  1. Efficacy as measured by improvements in gait and mobility.

    Time frame: from pre- to post-treatment during 20-day intervention.

    Efficacy will be measured by improvements in mobility and gait as measured by the Dynamic Gait Index, Timed Up and Go, Six- Minute Walk, and Falls Efficacy Scale.

Sponsors and collaborators

Lead sponsor

INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium

Other

Collaborators

  • U.S. Army Medical Research and Development Command

Registry information

Official study title

IMPROVING WALKING AND BALANCE IN VETERANS WITH TRAUMATIC BRAIN INJURY: A PILOT STUDY EXAMINING FEASIBILITY AND DOSAGE

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Aug 17, 2011
Registry last updated
Apr 26, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.